Glutamate and Schizophrenia: Pathophysiology and Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1875-6158|2|1|29-44

ISSN： 1568-0150

Source： Current Medicinal Chemistry - Central Nervous System Agents, Vol.2, Iss.1, 2002-03, pp. : 29-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function

By  

Current Neuropharmacology, Vol. 3, Iss. 1, 2005-01 ,pp. : 9-34

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate and Schizophrenia

By  

Current Neuropharmacology, Vol. 1, Iss. 4, 2003-12 ,pp. : 351-370

Bentham Science Publishers

Access to resources Recommend Favorite

The genetics of schizophrenia: glutamate not dopamine?

By Collier D.A.   Li T.  

European Journal of Pharmacology, Vol. 480, Iss. 1, 2003-11 ,pp. : 177-184

Elsevier

Access to resources Recommend Favorite

Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia

By Gothelf D.   Soreni N.   Nachman R.P.   Tyano S.   Hiss Y.   Reiner O.   Weizman A.  

European Neuropsychopharmacology, Vol. 10, Iss. 5, 2000-09 ,pp. : 389-395

Elsevier

Access to resources Recommend Favorite

Schizophrenia: From Dopamine to Glutamate and Back

By  

Current Medicinal Chemistry, Vol. 11, Iss. 3, 2004-02 ,pp. : 267-277

Bentham Science Publishers

Access to resources Recommend Favorite